Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-03-05 @ 9:41 AM
Study NCT ID:
NCT01770834
Status:
COMPLETED
Last Update Posted:
2018-03-02
First Post:
2013-01-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-25
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-16
First Submit QC Date:
None
Study First Post Date:
2013-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-28
Last Update Post Date:
2018-03-02
Last Update Post Date Type:
ACTUAL